北京天坛医院品牌怎么样 申请店铺

我要投票 北京天坛医院在男科医院行业中的票数:212 更新时间:2025-05-12
北京天坛医院是哪个国家的品牌?「北京天坛医院」是首都医科大学附属北京天坛医院旗下著名品牌。该品牌发源于北京市,由创始人王院长在1956年期间创立,经过多年的不懈努力和高速发展,现已成为行业的标杆品牌。

外推网助力北京天坛医院品牌出海!将品牌入驻外推网,定制北京天坛医院品牌推广信息,可以显著提高北京天坛医院产品曝光,简直是跨境电商爆单神器!目前仅需1000元/年哦~

北京天坛医院怎么样


首都医科大学附属北京天坛医院始建于1956年8月23日,是一所以神经外科为先导,神经科学为特色,集医、教、研、防为一体的三级甲等综合性医院。是世界三大神经外科研究中心之一、亚洲的神经外科临床、科研、教学基地。医院总占地面积83900.56平方米,建筑面积 92898.56平方米,编制床位950张,临床、医技科室45个,全院职工总数2787人。年门急诊量约140余万人次,年住院病人约3万人次,年手术量2万余例次。

北京市神经外科研究所、国家神经系统疾病临床医学研究中心、北京市伽玛刀治疗研究中心、北京市脑血管病抢救治疗中心、国家脑血管病创新药物临床评价技术平台、WHO在中国的神经科学培训合作中心、北京脑重大疾病研究院脑卒中研究所、北京脑重大疾病研究院脑肿瘤研究所、北京神外学院、首都医科大学第五临床医学院、全国脑血管病防治办公室、北京市脑血管病临床研究中心、北京市脑血管病防治指导办公室、中国卒中培训项目以及《中华神经外科杂志》、《中国卒中杂志》等一批机构设在我院。

功能神经外科和清华大学联合被授予神经调控工程中心称号;我院的脑血管病中心是北京市脑血管病临床研究中心和国家“十二五”重大新药创制脑血管病临床评价的依托平台;赵继宗教授获得了“2012年Walter E. Dandy神经外科学会荣誉奖”;戴建平教授入选美国科学院2012年新一批外籍院士,成为继巴德年、陈竺、韩启德之后又一来自中国的该院外籍院士;王拥军副院长获得 2012年首都危险疾病科技成果推广专项和北京市科技惠民奖,主编了2012 年卫生部颁布的《缺血性脑卒中诊断和诊疗质量控制》。

2013年12月19日赵继宗教授当选为中国科学院院士。

我院作为北京市医改第三批试点医院,实施了医药分开试点工作,深入推动了医院管理体制机制变革。开展电子病历、临床路径、DRGs付费、缩短平均住院日、抗菌药物监管治理、加强危急值的管理、处方点评、加强床位管理、优质护理服务等方面的工作。

我院承担了西藏自治区、新疆维吾尔自治区和内蒙古自治区所辖5所医院,以及东城区和丰台区的五所医院的对口支援任务。

医院全体职工在医院党委和领导班子的带领下,发扬王忠诚院士开拓创新、团结协作、严谨求实、艰苦奋斗、病人优先的精神,推动我国神经科学事业向更高水平发展。以“全心全意为病人服务”为宗旨,推进服务质量和医疗质量管理为核心的医疗管理体系;提升学科和人才队伍建设水平,培养更多热爱医院、有才华的专业和管理年轻人才;继续实施绩效管理,创建以绩效考核为核心的人力资源管理体系;完善各项管理监督机制,创建以成本核算为核心的后勤管理体系;推进新院迁建工作尽早进入建设阶段,推动天坛医院实现新的历史跨越,让天坛品牌永葆辉煌。


Beijing Tiantan Hospital, affiliated to Capital Medical University, was founded on August 23, 1956. It is a third-class comprehensive hospital with neurosurgery as the guide and neuroscience as the feature, integrating medicine, teaching, research and prevention. It is one of the three neurosurgery research centers in the world and the clinical, scientific and teaching base of neurosurgery in Asia. The hospital covers an area of 83900.56 square meters, with a building area of 92898.56 square meters. It has 950 beds, 45 clinical and medical technology departments, and 2787 employees. The annual outpatient and emergency treatment volume is about 1.4 million person times, the annual inpatient volume is about 30000 person times, and the annual operation volume is more than 20000. Beijing neurosurgery Research Institute, National Clinical Medicine Research Center for nervous system diseases, Beijing gamma knife treatment research center, Beijing cerebrovascular disease rescue and treatment center, national cerebrovascular disease innovative drug clinical evaluation technology platform, who China neuroscience training cooperation center, stroke research institute of Beijing Institute of major brain diseases, Beijing major brain disease research center The Institute of brain tumor research, Beijing Shenwai college, the fifth Clinical Medical College of Capital Medical University, the National Office of cerebrovascular disease prevention and control, Beijing clinical research center of cerebrovascular disease, Beijing cerebrovascular disease prevention and control guidance office, China stroke training program, China Journal of Neurosurgery, China stroke journal and other institutions are located in our hospital. Functional neurosurgery and Tsinghua University were jointly awarded the title of neuroregulation Engineering Center; the cerebrovascular disease center of our hospital is the supporting platform for clinical evaluation of Beijing cerebrovascular disease clinical research center and national "12th Five Year Plan" major new drug creation cerebrovascular disease; Professor Zhao Jizong won the "2012 Walter E. dandy neurosurgery society honorary Award"; Professor Dai Jianping was selected into American Science In 2012, a new group of foreign academicians of the Academy became another foreign academician from China after badian, Chen Zhu and Han Qide. Wang Yongjun, vice president of the Academy, won the special promotion project of scientific and technological achievements of dangerous diseases in the capital in 2012 and the Beijing Science and Technology Award for the benefit of the people, and edited the diagnosis and treatment quality control of ischemic stroke issued by the Ministry of health in 2012. On December 19, 2013, Professor Zhao Jizong was elected as an academician of the Chinese Academy of Sciences. As the third batch of pilot hospitals of Beijing medical reform, our hospital has carried out the pilot work of separating medicine and further promoted the reform of hospital management system and mechanism. Carry out the work of electronic medical record, clinical pathway, DRGs payment, shortening the average length of stay, antimicrobial drug supervision and management, strengthening the management of critical value, prescription review, strengthening bed management, quality nursing services, etc. Our hospital has undertaken the counterpart support tasks of five hospitals under the jurisdiction of Tibet Autonomous Region, Xinjiang Uygur Autonomous Region and Inner Mongolia Autonomous Region, as well as five hospitals in Dongcheng District and Fengtai District. Under the leadership of the hospital Party committee and the leading group, all staff of the hospital carry forward the spirit of Academician Wang Zhongli's pioneering innovation, unity and cooperation, rigorous and realistic, hard work and patient priority, and promote the development of neuroscience in China to a higher level. With the purpose of "serving patients wholeheartedly", promote the medical management system with service quality and medical quality management as the core; improve the level of discipline and talent team construction, cultivate more professional and management young talents who love hospitals and have talent; continue to implement performance management, create a human resource management system with performance assessment as the core; improve various management and supervision mechanisms To establish a logistics management system with cost accounting as the core; to promote the relocation of the new hospital to enter the construction stage as early as possible, to promote the Tiantan Hospital to achieve a new historical leap, so that the brand of Tiantan will remain brilliant forever.

本文链接: https://brand.waitui.com/5984c1b65.html 联系电话:请联系客服添加 联系邮箱:请联系客服添加

外推网广告位招租,每天只要9块9

7×24h 快讯

印度IT出口商LTIMindtree斩获4.5亿美元大单,创历史之最

印度软件服务出口商LTIMindtree周一表示,该公司拿下了一笔价值4.5亿美元的多年期大单,这是该公司有史以来最大的一笔交易。LTIMindtree称,客户是一家全球农业综合企业,但未透露其名称。(新浪财经)

2小时前

WHEE、DeepSeek、腾讯元宝、即梦AI入选AI原生App用户规模增长榜

36氪获悉,QuestMobile发布AI原生App用户规模增长TOP榜,美图公司旗下AI视觉创作工具WHEE获得AI图像处理赛道第一。一同入选的还有DeepSeek、腾讯元宝、即梦AI等。据介绍,WHEE“AI高清”功能可以将较低的分辨率图片提升至超清画质,同时保留细节与色彩的完整性,凭借此功能,今年2月WHEE登顶国内App Store分类榜第一位。

2小时前

华为与优必选科技正式签署全面合作协议

36氪获悉,华为与优必选科技在深圳正式签署全面合作协议。双方将围绕具身智能和人形机器人领域,在产品技术研发、场景应用及产业体系等开展创新合作。华为将依托全栈AI基础设施能力,支持优必选建设具身智能创新中心,并基于场景打造“人形机器人+智慧工厂”联合示范方案,开发家庭服务人形机器人(包含双足和轮式人形机器人)等方面展开合作,加速推动人形机器人从实验室创新向工业、家庭等场景的效率提升和落地复制。

2小时前

五连板*ST立航:不存在应披露而未披露的重大事项

36氪获悉,*ST立航披露股票交易风险提示公告称,截至 2025 年 5 月 12 日,公司股票已连续5个交易日涨停,公司股票价格近期波动较大,敬请广大投资者注意投资风险,理性投资。经公司自查,目前生产经营活动一切正常,市场环境、行业政策没有发生重大调整,内部生产经营秩序正常。经公司自查,除了在指定媒体上已公开披露的信息外,不存在应披露而未披露的重大事项。

2小时前

保险金信托门槛将降至100万以下,“抢滩”服务信托下的转型共识

保险金信托设立门槛将首降。近日,从平安信托获悉,其保险金信托门槛拟降低至100万以下,但具体金额还未定。如若落地,这将是信托业首次将保险金信托初始设立门槛下探至100万以下。(21财经)

2小时前

本页详细列出关于北京天坛医院的品牌信息,含品牌所属公司介绍,北京天坛医院所处行业的品牌地位及优势。
咨询